Evaluation of Maternal Mental Health Following Ultrasonography Detection of Fetal Congenital Anomalies

NCT ID: NCT06594952

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate maternal mental health during antenatal and postnatal periods after Ultrasonography diagnosis of fetal anomalies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fetal congenital anomalies are responsible for a great deal of abortions in desired pregnancies . In clinical practice, prenatal screening programs in 1st and 2nd trimester target both chromosomal and structural abnormalities. These congenital anomalies are classified as minor and major anomalies than may lead to death or stillbirth . Half of all anomalies are detectable during weeks 18-22 of pregnancy. Due to the advances occurring in Ultrasonography and screening paradigms, the rate of diagnosed anomalies is increasing dramatically which in turn leading to psychological distress in the pregnant mother. Receiving a diagnosis of fetal anomaly is a highly stressful and potentially traumatic event that can elicit immediate feelings of grief, loss, anger, depression, and anxiety. However, the foreknowledge of a fetal anomaly during pregnancy may enable the mother to prepare mentally resulting in reduced maternal stress after delivery. The American College of Medical Genetics recommends underscoring the importance of psychological assessment and substantive communication with parents facing a prenatal diagnosis of fetal anomaly. Despite the accessibility of establishing the significant symptoms of maternal psychological distress, the evidence on the definite nature of this distress in consideration to other life stressors and an accurate the prediction of women vulnerability in the critical period have not been clear yet due to many methodological issues. Identification of women at highest risk for poor adaptation to the diagnosis may allow for targeted psychological support services for those most vulnerable.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mental Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

minor anomalies group

pregnant women with minor fetal structural anomaly detected by ultrasound.

Questionnaire and Physical Exam

Intervention Type OTHER

Diagnosis of Anxiety using the state-trait anxiety inventory scale (STAI). Depression using Edinburgh Postnatal Depression Scale (EPDS)

* Coping using the Brief Coping Scale
* Socioeconomic using the Socioeconomic Scale of Egypt
* Personality using the short-form Eysenck Personality Questionnaire-Revised (EPQ-R)
* Behaviour using Impact of Erect Scale (IES-22)

major anomalies group

pregnant women with major fetal structural anomaly detected by ultrasound

Questionnaire and Physical Exam

Intervention Type OTHER

Diagnosis of Anxiety using the state-trait anxiety inventory scale (STAI). Depression using Edinburgh Postnatal Depression Scale (EPDS)

* Coping using the Brief Coping Scale
* Socioeconomic using the Socioeconomic Scale of Egypt
* Personality using the short-form Eysenck Personality Questionnaire-Revised (EPQ-R)
* Behaviour using Impact of Erect Scale (IES-22)

Control Group

Pregnant women with normal ultrasound.

Questionnaire and Physical Exam

Intervention Type OTHER

Diagnosis of Anxiety using the state-trait anxiety inventory scale (STAI). Depression using Edinburgh Postnatal Depression Scale (EPDS)

* Coping using the Brief Coping Scale
* Socioeconomic using the Socioeconomic Scale of Egypt
* Personality using the short-form Eysenck Personality Questionnaire-Revised (EPQ-R)
* Behaviour using Impact of Erect Scale (IES-22)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire and Physical Exam

Diagnosis of Anxiety using the state-trait anxiety inventory scale (STAI). Depression using Edinburgh Postnatal Depression Scale (EPDS)

* Coping using the Brief Coping Scale
* Socioeconomic using the Socioeconomic Scale of Egypt
* Personality using the short-form Eysenck Personality Questionnaire-Revised (EPQ-R)
* Behaviour using Impact of Erect Scale (IES-22)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women with confirmed pregnancy with viable fetus (whether singleton or multiple)
* Fetal anomaly should be diagnosed with ultrasonography (whether minor or major) after 12 weeks of gestational age

Exclusion Criteria

\- Women with history of psychiatric disorders.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Areej Abdalrahman Khamees

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Abbas Professor, MD

Role: CONTACT

+201003385183

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Maternal psychology on anomaly

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Antimanic Drug Use in Pregnancy
NCT00585702 COMPLETED
Psychatric Effect of Ectopic Pregnancy
NCT06721403 NOT_YET_RECRUITING